Cargando…

Effects of Vaccination against COVID-19 in Chronic Spontaneous and Inducible Urticaria (CSU/CIU) Patients: A Monocentric Study

Background: Patients affected by pre-existing chronic spontaneous/Inducible urticaria (CSU/CIU) still feel unsafe due to the potential risk of an Adverse Event Following Immunization (AEFI) and Cutaneous Adverse Reactions (CARs) of COVID-19 vaccines. The appropriate management in this field remains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grieco, Teresa, Ambrosio, Luca, Trovato, Federica, Vitiello, Martina, Demofonte, Ilaria, Fanto, Marta, Paolino, Giovanni, Pellacani, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999670/ https://www.ncbi.nlm.nih.gov/pubmed/35407429 http://dx.doi.org/10.3390/jcm11071822

Ejemplares similares

Suppression of Basophil FcεRI Activation by Serum from Active Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU) Subjects
por: Sterba, Patricia M, et al.
Publicado: (2015)

Omalizumab in chronic spontaneous urticaria (CSU): experience in three cases
por: Valle, Solange Oliveira Rodrigues, et al.
Publicado: (2015)

Cutaneous Reactions to COVID-19 Vaccines in a Monocentric Study: A Case Series
por: Cantisani, Carmen, et al.
Publicado: (2022)

Clinical Remission of Chronic Spontaneous Urticaria (CSU): A Targeted Literature Review
por: Balp, Maria-Magdalena, et al.
Publicado: (2021)

The burden of chronic spontaneous urticaria is substantial: Real‐world evidence from ASSURE‐CSU
por: Maurer, M., et al.
Publicado: (2017)

Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU)()
por: Jang, Jae-Hyuk, et al.
Publicado: (2022)

ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria
por: Weller, Karsten, et al.
Publicado: (2015)

Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE‐CSU
por: Sussman, G., et al.
Publicado: (2018)

Loratadine vs Rupatadine: Unearthing the Capital Choice in Chronic Idiopathic Urticaria (CIU) – A Randomized Controlled Trial
por: Fayaz, Syed H, et al.
Publicado: (2021)

Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome
por: Lima, Hermenio, et al.
Publicado: (2017)

Type I and type IIb autoimmune chronic spontaneous urticaria: Using common clinical tools for endotyping patients with CSU
por: Sella, Juliana A., et al.
Publicado: (2023)

O10 - Rupatadine is effective and safe in the treatment of Chronic Spontaneous Urticaria (CSU) in pediatric patients (2-11 years old)
por: Potter, Paul, et al.
Publicado: (2014)

Presence of positive skin prick tests to inhalant allergens and markers of T2 inflammation in subjects with chronic spontaneous urticaria (CSU): a systematic literature review
por: Wong, Melanie Mitsui, et al.
Publicado: (2020)

Neutral Dietary Effects of Two MicroRNAs, Csu-Novel-260 and Csu-Mir-14, on the Non-Target Arthropod Folsomia candida
por: Zhou, Qinli, et al.
Publicado: (2023)

Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies
por: Mandel, Victor D., et al.
Publicado: (2018)

Thyroid Autoimmunity in CSU: A Potential Marker of Omalizumab Response?
por: Asero, Riccardo, et al.
Publicado: (2023)

Prospective, monocentric, observational study of the long-term effectiveness of omalizumab in chronic urticaria
por: Traidl, Stephan, et al.
Publicado: (2023)

Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria
por: Durda, J., et al.
Publicado: (2017)

Immunological events in chronic spontaneous urticaria
por: Ferrer, Marta
Publicado: (2015)

Comparison of Urticaria Activity Score Over 7 Days (UAS7) Values Obtained from Once-Daily and Twice-Daily Versions: Results from the ASSURE-CSU Study
por: Hollis, Kelly, et al.
Publicado: (2018)

Anifrolumab for Moderate and Severe Muco-Cutaneous Lupus Erythematosus: A Monocentric Experience and Review of the Current Literature
por: Paolino, Giovanni, et al.
Publicado: (2023)

Profile of omalizumab in the treatment of chronic spontaneous urticaria
por: Labrador-Horrillo, Moises, et al.
Publicado: (2015)

Basophils priming in patients with chronic spontaneous urticaria
por: Gomułka, Krzysztof, et al.
Publicado: (2021)

Syphilis, the Great Imitator—Clinical and Dermoscopic Features of a Rare Presentation of Secondary Syphilis
por: Cantisani, Carmen, et al.
Publicado: (2023)

Treatment of Chronic Spontaneous Urticaria
por: Kaplan, Allen P.
Publicado: (2012)

What Basophil Testing Tells Us About CSU Patients – Results of the CORSA Study
por: Marcelino, João, et al.
Publicado: (2021)

Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications
por: Puxeddu, Ilaria, et al.
Publicado: (2019)

Autoimmune Theories of Chronic Spontaneous Urticaria
por: Bracken, Sonali J., et al.
Publicado: (2019)

Emerging Therapies in Chronic Spontaneous Urticaria
por: Min, Taek Ki, et al.
Publicado: (2019)

Chronic Spontaneous Urticaria: An Etiopathogenic Study
por: Maheshwari, Apoorva, et al.
Publicado: (2022)

Biologic drugs in chronic spontaneous urticaria
por: Licari, Amelia, et al.
Publicado: (2021)

Definition of Recurrent Chronic Spontaneous Urticaria
por: MELÉ-NINOT, Gemma, et al.
Publicado: (2020)

Mediators of Inflammation and Angiogenesis in Chronic Spontaneous Urticaria: Are They Potential Biomarkers of the Disease?
por: Puxeddu, Ilaria, et al.
Publicado: (2017)

Effects of dupilumab in type 1 neurofibromatosis coexisting with severe atopic dermatitis()()
por: Chello, Camilla, et al.
Publicado: (2021)

CSU52, a novel regulator functions as a repressor of L-sorbose utilization in Candida albicans
por: Pullepu, Dileep, et al.
Publicado: (2021)

Verantwortung für Frieden, Freiheit und Wohlstand – außen- und sicherheitspolitische Grundsätze der CDU/CSU
por: Wadephul, Johann David
Publicado: (2021)

Isolation and characterization of a VHH targeting the Acinetobacter baumannii cell surface protein CsuA/B
por: Lei, Eric K., et al.
Publicado: (2023)

In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticaria
por: Moñino‐Romero, Sherezade, et al.
Publicado: (2023)

OMALIZUMAB IN TREATMENT-RESISTANT CHRONIC SPONTANEOUS URTICARIA
por: Godse, Kiran V
Publicado: (2011)

EBASTINE IN CHRONIC SPONTANEOUS URTICARIA IN HIGHER DOSES
por: Godse, Kiran V
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hvuvdlnc6romul2kvr9rr6rmp1